Advertisement
New Zealand markets closed

  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     

  • NZD/USD

    0.5949
    +0.0012 (+0.21%)
     

  • NZD/EUR

    0.5547
    +0.0001 (+0.02%)
     

  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     

  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     

  • OIL

    82.96
    +0.15 (+0.18%)
     

  • GOLD

    2,330.70
    -7.70 (-0.33%)
     

  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     

  • FTSE

    8,040.38
    -4.43 (-0.06%)
     

  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     

  • DAX

    18,088.70
    -48.95 (-0.27%)
     

  • Hang Seng

    17,224.09
    +22.82 (+0.13%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • NZD/JPY

    92.5680
    +0.4530 (+0.49%)
     

Globe Life (GL) Reports Q1 Earnings: What Key Metrics Have to Say

Zacks Equity Research
·2-min read

Globe Life (GL) reported $1.35 billion in revenue for the quarter ended March 2023, representing a year-over-year increase of 2.8%. EPS of $2.53 for the same period compares to $1.70 a year ago.

The reported revenue represents a surprise of -0.88% over the Zacks Consensus Estimate of $1.36 billion. With the consensus EPS estimate being $2.47, the EPS surprise was +2.43%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

ADVERTISEMENT

Here is how Globe Life performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Revenue- Total premium: $1.10 billion versus the five-analyst average estimate of $1.10 billion. The reported number represents a year-over-year change of +2.2%.

  • Revenue- Net investment income: $257.11 million versus the five-analyst average estimate of $256.15 million. The reported number represents a year-over-year change of +5.4%.

  • Revenue- Health premium: $322.49 million versus the three-analyst average estimate of $327.85 million. The reported number represents a year-over-year change of +1.7%.

  • Revenue- Life premium: $772.60 million versus the three-analyst average estimate of $775.50 million. The reported number represents a year-over-year change of +2.4%.

  • Revenue- Other income (loss): $0.05 million versus $0.92 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -69.5% change.

View all Key Company Metrics for Globe Life here>>>

Shares of Globe Life have returned +0.1% over the past month versus the Zacks S&P 500 composite's +0.4% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Globe Life Inc. (GL) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research